Glenn Goldstein, DO
Interventional Pain Medicine · Howard Beach, NYNPI 1811901044
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,088 of the $7,169 with a category attached, or 71.0%. Boston Scientific accounts for 68.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $2,098 and has fallen 70.2% since, to $625 in 2025.
Across 102 payments — averaging $70.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Genesys Orthopedics Systems, L.L.C.$780
- Amgen$487
- Spinal Simplicity, LLC$353
- SPR Therapeutics, Inc$246
- Abbott$108
- plus $318 from 6 others
What the payments were for
- Travel & lodging$2,06629%
- Food & beverage$5,08871%
- Gifts$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 51 | $4,877 |
| Genesys Orthopedics Systems, L.L.C. | 6 | $780 |
| Amgen | 29 | $487 |
| Spinal Simplicity, LLC | 5 | $353 |
| SPR Therapeutics, Inc | 2 | $246 |
| Abbott | 1 | $108 |
| Curonix LLC | 1 | $98 |
| Relievant Medsystems, Inc. | 1 | $96 |
| Pacira Therapeutics, Inc. | 2 | $37 |
| Nevro Corp. | 1 | $37 |
| Bioventus LLC | 2 | $34 |
| Vertiflex, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,169 in reported general payments places this provider in the 65th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 81 | $1,193 |
| Diclofenac Sodium | 56 | $560 |
| Oxycodone Hcl | 30 | $313 |
| Tramadol Hcl | 93 | $299 |
| Pregabalin | 17 | $267 |
| Misoprostol | 16 | $202 |
| Naproxen | 21 | $78 |
| Ibuprofen | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Howard Beach
- Corey HunterNew York$446K
- Neel MehtaNew York$432K
- Hemant KaliaRochester$179K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Suelane OuroNew York$68K
- Gerard DegregorisNew York$49K
- Jafar SiddiquiWilliamsville$45K
- Alexander WeingartenSyosset$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.